Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells

  • Fuentes Varela, Pedro
  • Sese Faustino, Marta
  • Guijarro Carrillo, Pedro Jesus
  • Emperador Melero, Marta Isabel
  • Sánchez-Redondo, Sara
  • Peinado, Héctor
  • Hümmer, Stefan
  • Ramon y Cajal Agüeras, Santiago
Molècules de senyalització extracel·lular; Mecanismes de la malaltia; Metàstasi, Moléculas de señalización extracelular; Mecanismos de la enfermedad; Metástasis, Extracellular signalling molecules, Mechanisms of disease; Metastasis, Metastasis, the spread of malignant cells from a primary tumour to distant sites, causes 90% of cancer-related deaths. The integrin ITGB3 has been previously described to play an essential role in breast cancer metastasis, but the precise mechanisms remain undefined. We have now uncovered essential and thus far unknown roles of ITGB3 in vesicle uptake. The functional requirement for ITGB3 derives from its interactions with heparan sulfate proteoglycans (HSPGs) and the process of integrin endocytosis, allowing the capture of extracellular vesicles and their endocytosis-mediated internalization. Key for the function of ITGB3 is the interaction and activation of focal adhesion kinase (FAK), which is required for endocytosis of these vesicles. Thus, ITGB3 has a central role in intracellular communication via extracellular vesicles, proposed to be critical for cancer metastasis., The authors thank Hector Peinado and his laboratory team (Microenvironment & Metastasis Group, Molecular Oncology Program, Spanish National Cancer Research Centre (CNIO)). The authors thank Dr. Manel Bosch for helpful discussion and assistance with confocal microscopy. The authors thank Dr. Anne Spang and Dr Jordi Berenguer for helpful suggestions and discussion on the paper, and Jane Marshall for language review and editing support. This work was supported by Fondo de Investigaciones Sanitarias (PI14/01320), Redes Temáticas de Investigación Cooperativa en Salud (RD12/0036/0057) and CIBERONC (CB16/12/00363). SRC acknowledges support from the Generalitat de Catalunya (2014 SGR 1131). The CRG/UPF Proteomics Unit is part of the Spanish Infrastructure for Omics Technologies (ICTS OmicsTech) and it is a member of the ProteoRed PRB3 consortium which is supported by grant PT17/0019 of the PE I + D + i 2013-2016 from the Instituto de Salud Carlos III (ISCIII) and ERDF.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Hypoxia-mediated translational activation of ITGB3 in breast cancer cells enhances TGF-β signaling and malignant features in vitro and in vivo

  • Sesé, Marta|||0000-0003-1473-4833
  • Fuentes Varela, Pedro|||0000-0001-8471-0197
  • Esteve-Codina, Anna|||0000-0003-0361-2873
  • Bejar Serrano, Eva|||0000-0002-1843-3010
  • McGrail, Kimberley|||0000-0001-7227-7306
  • Thomas, George|||0000-0002-1236-1714
  • Aasen, Trond|||0000-0003-0763-2695
  • Ramón y Cajal, Santiago|||0000-0002-3867-1390
Breast cancer is the most prevalent malignancy in women and there is an urgent need for new therapeutic drugs targeting aggressive and metastatic subtypes, such as hormone-refractory triple-negative breast cancer (TNBC). Control of protein synthesis is vital to cell growth and tumour progression and permits increased resistance to therapy and cellular stress. Hypoxic cancer cells attain invasive and metastatic properties and chemotherapy resistance, but the regulation and role of protein synthesis in this setting is poorly understood. We performed a polysomal RNA-Seq screen in non-malignant breast epithelial (MCF10A) and TNBC (MDA-MB-231) cells exposed to normoxic or hypoxic conditions and/or treated with an mTOR pathway inhibitor. Analysis of both the transcriptome and the translatome identified mRNA transcripts translationally activated or repressed by hypoxia in an mTOR-dependent or -independent manner. Integrin beta 3 (ITGB3) was translationally activated in hypoxia and its knockdown increased apoptosis and reduced survival and migration, particularly under hypoxic conditions. Moreover, ITGB3 was required for sustained TGF-β pathway activation and for the induction of Snail and associated epithelial-mesenchymal transition markers. ITGB3 downregulation significantly reduced lung metastasis and improved overall survival in mice. Collectively, these data suggest that ITGB3 is translationally activated in hypoxia and regulates malignant features, including epithelial-mesenchymal transition and cell migration, through the TGF-β pathway, revealing a novel angle for the treatment of therapy-resistant hypoxic tumours.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Beyond molecular tumor heterogeneity, protein synthesis takes control

  • Ramón y Cajal, Santiago|||0000-0002-3867-1390
  • Castellvi, Josep|||0000-0001-5745-9996
  • Hümmer, Stefan|||0000-0002-8184-3872
  • Peg, Vicente|||0000-0002-5203-6166
  • Pelletier, Jerry
  • Sonenberg, Nahum
One of the daunting challenges facing modern medicine lies in the understanding and treatment of tumor heterogeneity. Most tumors show intra-tumor heterogeneity at both genomic and proteomic levels, with marked impacts on the responses of therapeutic targets. Therapeutic target-related gene expression pathways are affected by hypoxia and cellular stress. However, the finding that targets such as eukaryotic initiation factor (eIF) 4E (and its phosphorylated form, p-eIF4E) are generally homogenously expressed throughout tumors, regardless of the presence of hypoxia or other cellular stress conditions, opens the exciting possibility that malignancies could be treated with therapies that combine targeting of eIF4E phosphorylation with immune checkpoint inhibitors or chemotherapy.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Interplay between ncRNAs and cellular communication, A proposal for understanding cell-specific signaling pathways

  • Ramón y Cajal, Santiago|||0000-0002-3867-1390
  • Segura, M. F.
  • Hümmer, Stefan|||0000-0002-8184-3872
Intercellular communication is essential for the development of specialized cells, tissues, and organs and is critical in a variety of diseases including cancer. Current knowledge states that different cell types communicate by ligand-receptor interactions: hormones, growth factors, and cytokines are released into the extracellular space and act on receptors, which are often expressed in a cell-type-specific manner. Non-coding RNAs (ncRNAs) are emerging as newly identified communicating factors in both physiological and pathological states. This class of RNA encompasses microRNAs (miRNAs, well-studied post-transcriptional regulators of gene expression), long non-coding RNAs (lncRNAs) and other ncRNAs. lncRNAs are diverse in length, sequence, and structure (linear or circular), and their functions are described as transcriptional regulation, induction of epigenetic changes and even direct regulation of protein activity. They have also been reported to act as miRNA sponges, interacting with miRNA and modulating its availability to endogenous mRNA targets. Importantly, lncRNAs may have a cell-type-specific expression pattern. In this paper, we propose that lncRNA-miRNA interactions, analogous to receptor-ligand interactions, are responsible for cell-type-specific outcomes. Specific binding of miRNAs to lncRNAs may drive cell-type-specific signaling cascades and modulate biochemical feedback loops that ultimately determine cell identity and response to stress factors.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Characterization of Kelch domain-containing protein 7B in breast tumours and breast cancer cell lines

  • Martín-Pardillos, A.|||0000-0003-1717-8465
  • Ramón y Cajal, Santiago|||0000-0002-3867-1390
Adenocarcinomas exhibit great heterogeneity, with many genetic and epigenetic alterations. The Kelch domain-containing protein 7B (KLHDC7B) has recently been identified as epigenetically modified and upregulated in breast cancer. The potential reversibility of epigenetic states offers exciting possibilities for novel cancer diagnostics and drugs. However, to properly evaluate specific inhibitors, the role of KLHDC7B in the development and progression of breast cancer should be established. With that objective in mind, the present study investigated a series of human breast tumours and correlated their clinicopathology, according to the Elston-Ellis modification of the Scarff-Bloom-Richardson (SBR) grading system, with KLHDC7B mRNA expression, analysed using quantitative PCR (qPCR). The results revealed that KLHDC7B was significantly upregulated in grade 3 tumours, and that KLHDC7B expression varied according to the tumour grade and the individual, being downregulated in well-differentiated and moderately-differentiated tumours (grade 1-2) and upregulated in poorly-differentiated tumours (grade 3). Immunohistochemical staining revealed that ductal tumours and tumours with a higher percentage of Ki67 positive cells showed the highest levels of KLHDC7B. Receptor expression, HER, p53 status, presence of metastasis, and vascular invasion showed no association with KLHDC7B expression. Previous studies have proposed KLHDC7B as an epigenetic marker of breast cancer. We propose that KLHDC7B should be used as a marker for poorly-differentiated tumours only; use of KLHDC7B without considering tumour grade could lead to an inaccurate diagnosis. Finally, we suggest the appropriate breast cancer cell lines to use to determine the functions of KLHDC7B. KLHDC7B expression was tested in the non-tumour cell line MCF-10A and in the breast cancer cell lines MCF-7, MDA-MB-231 and MDA-MB-468, using qPCR and western blotting. The results revealed that all tested cancer cell lines overexpressed KLHDC7B mRNA, but MDA-MB-468 exhibited a much lower level of protein expression relative to mRNA. Although the breast cancer cell lines used may be appropriate for studying KLHDC7B epigenetic status, MDA-MB-468 should be excluded from functional experiments.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The role of clonal communication and heterogeneity in breast cancer

  • Martín-Pardillos, A.|||0000-0003-1717-8465
  • Valls Chiva, Á.
  • Bande Vargas, G.
  • Hurtado Blanco, P.
  • Piñeiro Cid, R.
  • Guijarro, Pedro J.
  • Hümmer, Stefan|||0000-0002-8184-3872
  • Bejar Serrano, Eva|||0000-0002-1843-3010
  • Rodriguez-Casanova, A.
  • Diaz-Lagares, Angel|||0000-0002-9114-9227
  • Castellvi, Josep|||0000-0001-5745-9996
  • Miravet-Verde, S.
  • Serrano, L.
  • Lluch-Senar, M.
  • Sebastian, V.
  • Bribian, A.
  • López-Mascaraque, L.
  • López-López, R.
  • Ramón y Cajal, S.
Background: Cancer is a rapidly evolving, multifactorial disease that accumulates numerous genetic and epigenetic alterations. This results in molecular and phenotypic heterogeneity within the tumor, the complexity of which is further amplified through specific interactions between cancer cells. We aimed to dissect the molecular mechanisms underlying the cooperation between different clones. Methods: We produced clonal cell lines derived from the MDA-MB-231 breast cancer cell line, using the UbC-StarTrack system, which allowed tracking of multiple clones by color: GFP C3, mKO E10 and Sapphire D7. Characterization of these clones was performed by growth rate, cell metabolic activity, wound healing, invasion assays and genetic and epigenetic arrays. Tumorigenicity was tested by orthotopic and intravenous injections. Clonal cooperation was evaluated by medium complementation, co-culture and co-injection assays. Results: Characterization of these clones in vitro revealed clear genetic and epigenetic differences that affected growth rate, cell metabolic activity, morphology and cytokine expression among cell lines. In vivo, all clonal cell lines were able to form tumors; however, injection of an equal mix of the different clones led to tumors with very few mKO E10 cells. Additionally, the mKO E10 clonal cell line showed a significant inability to form lung metastases. These results confirm that even in stable cell lines heterogeneity is present. In vitro, the complementation of growth medium with medium or exosomes from parental or clonal cell lines increased the growth rate of the other clones. Complementation assays, co-growth and co-injection of mKO E10 and GFP C3 clonal cell lines increased the efficiency of invasion and migration. Conclusions: These findings support a model where interplay between clones confers aggressiveness, and which may allow identification of the factors involved in cellular communication that could play a role in clonal cooperation and thus represent new targets for preventing tumor progression.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

Clinical implications of intratumor heterogeneity, challenges and opportunities

  • Ramón y Cajal, Santiago|||0000-0002-3867-1390
  • Sesé, Marta|||0000-0003-1473-4833
  • Capdevila, Claudia
  • Aasen, Trond|||0000-0003-0763-2695
  • De Mattos-Arruda, Leticia|||0000-0002-4992-3645
  • Diaz-Cano, Salvador J.
  • Hernandez-Losa, Javier|||0000-0003-1526-3201
  • Castellvi, Josep|||0000-0001-5745-9996
In this review, we highlight the role of intratumoral heterogeneity, focusing on the clinical and biological ramifications this phenomenon poses. Intratumoral heterogeneity arises through complex genetic, epigenetic, and protein modifications that drive phenotypic selection in response to environmental pressures. Functionally, heterogeneity provides tumors with significant adaptability. This ranges from mutual beneficial cooperation between cells, which nurture features such as growth and metastasis, to the narrow escape and survival of clonal cell populations that have adapted to thrive under specific conditions such as hypoxia or chemotherapy. These dynamic intercellular interplays are guided by a Darwinian selection landscape between clonal tumor cell populations and the tumor microenvironment. Understanding the involved drivers and functional consequences of such tumor heterogeneity is challenging but also promises to provide novel insight needed to confront the problem of therapeutic resistance in tumors.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Integrating clinical, molecular, proteomic and histopathological data within the tissue context, tissunomics

  • Ramón y Cajal, Santiago|||0000-0002-3867-1390
  • Hümmer, Stefan|||0000-0002-8184-3872
  • Peg, Vicente|||0000-0002-5203-6166
  • Matías-Guiu, Xavier|||0000-0002-7201-6605
  • de Torres, Inés|||0000-0002-5495-9140
  • Castellvi, Josep|||0000-0001-5745-9996
  • Martinez-Saez, Elena|||0000-0001-6004-5364
  • Hernandez-Losa, Javier|||0000-0003-1526-3201
Malignant tumours show a marked degree of morphological, molecular and proteomic heterogeneity. This variability is closely related to microenvironmental factors and the location of the tumour. The activation of genetic alterations is very tissue-dependent and only few tumours have distinct genetic alterations. Importantly, the activation state of proteins and signaling factors is heterogeneous in the primary tumour and in metastases and recurrences. The molecular diagnosis based only on genetic alterations can lead to treatments with unpredictable responses, depending on the tumour location, such as the tumour response in melanomas versus colon carcinomas with mutations. Therefore, we understand that the correct evaluation of tumours requires a system that integrates both morphological, molecular and protein information in a clinical and pathological context, where intratumoral heterogeneity can be assessed. Thus, we propose the term 'tissunomics', where the diagnosis will be contextualised in each tumour based on the complementation of the pathological, molecular, protein expression, environmental cells and clinical data.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells

  • Fuentes Varela, Pedro|||0000-0001-8471-0197
  • Sesé, Marta|||0000-0003-1473-4833
  • Guijarro, Pedro J.
  • Emperador, Marta|||0000-0002-8538-4319
  • Sánchez-Redondo, Sara
  • Peinado, Héctor|||0000-0002-4256-3413
  • Hümmer, Stefan|||0000-0002-8184-3872
  • Ramón y Cajal, Santiago|||0000-0002-3867-1390
Metastasis, the spread of malignant cells from a primary tumour to distant sites, causes 90% of cancer-related deaths. The integrin ITGB3 has been previously described to play an essential role in breast cancer metastasis, but the precise mechanisms remain undefined. We have now uncovered essential and thus far unknown roles of ITGB3 in vesicle uptake. The functional requirement for ITGB3 derives from its interactions with heparan sulfate proteoglycans (HSPGs) and the process of integrin endocytosis, allowing the capture of extracellular vesicles and their endocytosis-mediated internalization. Key for the function of ITGB3 is the interaction and activation of focal adhesion kinase (FAK), which is required for endocytosis of these vesicles. Thus, ITGB3 has a central role in intracellular communication via extracellular vesicles, proposed to be critical for cancer metastasis. The integrin ITGB3 has been described to play an essential role in breast cancer metastasis, but the precise mechanisms remain undefined. Here the authors describe thus far unknown roles of ITGB3 in the uptake of extracellular vesicles, required for colony growth of breast cancer cells
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells

  • Fuentes Varela, Pedro
  • Sese Faustino, Marta
  • Guijarro Carrillo, Pedro Jesus
  • Emperador Melero, Marta Isabel
  • Sánchez-Redondo, Sara
  • Peinado, Héctor
  • Hümmer, Stefan
  • Ramon y Cajal Agüeras, Santiago
Molècules de senyalització extracel·lular; Mecanismes de la malaltia; Metàstasi, Moléculas de señalización extracelular; Mecanismos de la enfermedad; Metástasis, Extracellular signalling molecules, Mechanisms of disease; Metastasis, Metastasis, the spread of malignant cells from a primary tumour to distant sites, causes 90% of cancer-related deaths. The integrin ITGB3 has been previously described to play an essential role in breast cancer metastasis, but the precise mechanisms remain undefined. We have now uncovered essential and thus far unknown roles of ITGB3 in vesicle uptake. The functional requirement for ITGB3 derives from its interactions with heparan sulfate proteoglycans (HSPGs) and the process of integrin endocytosis, allowing the capture of extracellular vesicles and their endocytosis-mediated internalization. Key for the function of ITGB3 is the interaction and activation of focal adhesion kinase (FAK), which is required for endocytosis of these vesicles. Thus, ITGB3 has a central role in intracellular communication via extracellular vesicles, proposed to be critical for cancer metastasis., The authors thank Hector Peinado and his laboratory team (Microenvironment & Metastasis Group, Molecular Oncology Program, Spanish National Cancer Research Centre (CNIO)). The authors thank Dr. Manel Bosch for helpful discussion and assistance with confocal microscopy. The authors thank Dr. Anne Spang and Dr Jordi Berenguer for helpful suggestions and discussion on the paper, and Jane Marshall for language review and editing support. This work was supported by Fondo de Investigaciones Sanitarias (PI14/01320), Redes Temáticas de Investigación Cooperativa en Salud (RD12/0036/0057) and CIBERONC (CB16/12/00363). SRC acknowledges support from the Generalitat de Catalunya (2014 SGR 1131). The CRG/UPF Proteomics Unit is part of the Spanish Infrastructure for Omics Technologies (ICTS OmicsTech) and it is a member of the ProteoRed PRB3 consortium which is supported by grant PT17/0019 of the PE I + D + i 2013-2016 from the Instituto de Salud Carlos III (ISCIII) and ERDF.